Certainty Korea 2026

日期： 2026 年 6 月 18 日, 星期四

时间： 9:30am – 4:25pm

地点： Seoul, Korea

Certainty by Certara provides valuable opportunities to connect you with industry leaders and modeling & simulation (M&S) experts. Certara’s experts and guest speakers present the latest regulatory updates, applied case studies, and the cutting-edge technologies including AI/ML related to Model-informed Drug Development, clinical pharmacology, Pharmacometrics, QSP, PBPK, and more.

We hope this annual event will help you connect with innovative researchers across various pharmaceutical companies and bring the innovations to your team.

概述

日期 & 时间：9:30am – 4:25pm, Thursday, June 18th
Reception desk opens at: 9:00am
会场：Naru Seoul MGallery Ambassador, 2nd floor
注册费：Free of charge

点击报名

议程

Speakers’ biography (PDF): Coming soon
Timetable with speaker information (PDF): Coming soon

Morning Sessions

Global MIDD Regulatory Landscape: FDA & EMA Updates

Modeling & Simulation approaches used for regulatory submissions

[Guest Speaker] Innovative Bispecific Translational Development: CT-P72 QSP case
Jongin Kim, DVM, PhD Director, New Drug Development, Celltrion

Strategy First: Translational modeling from preclinical to clinical - Case studies of FIH dose justification

Digital Data Flow (DDF) from 3D to 4D

Group photo & Lunch break & Demo booth

Afternoon Sessions

Enabling AI-driven Decision making from Discovery to Submissions Towards Increased Clinical Drug Candidate Success - Today and Future Vision

[Guest Speaker] (TBC) Data-driven License Out Success Stories

[Guest Speaker] Considerations for Non-Clinical Development from the Perspective of a Scientific Open Innovator
Sujin Ahn, PhD Executive Officer, Drug Metabolism and Pharmacokinetics (DMPK), Yuhan Corporation

Regulatory Gap Analysis in the Korean Market: Trends and Strategic Insight

Optimal dosing, optimal outcomes: PBPK case studies for ADCs